GSK received United States FDA approval for Juluca in 2017, a once-daily, single pill 2DR regimen for HIV. Juluca combines dolutegravir with rilpivirine (....
15.00
2
Apr, 2020
Atripla Drug Sales & Forecast
GileadSciences drug Atripla is an oral formulation indicated as a complete regimen for the treatment of HIV-1 infection in certain patients. Atripla is a ....
15.00
3
Apr, 2020
Biktarvy Drug Sales & Forecast
GileadSciences drug Biktarvy is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients. Biktarvy is a single tablet....
15.00
4
Apr, 2020
Odefsey Drug Sales & Forecast
GileadSciences drug Odefsey is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients. Odefsey is a single tablet r....
15.00
Confirm All Clear!
Do You Realy want to delete all items from you CART?